4 Which brings us to weight loss medication
Available: (accessed 2025 Feb
(The FDA is expediting review of one such drug, survodutide, for liver-disease patients.) Meanwhile, GLP-1-based drugs appear to protect against cardiovascular disease, even independent of weight loss
You might be taking this supplement to support your liver, brighten your skin, or boost your overall antioxidant defense
It tells the pancreas to release insulin
Therefore it is very possible that other companies will enter the space in the future, if they develop candidates with comparable efficacy. The result is what industry insiders see as a quantum leap in pharmaceuticals which, ironically, is still likely to ultimately result in an age-old boom and bust pattern in the industry of one or two companies benefiting from a scientific breakthrough only to then lose momentum as others later succeed in different spheres